{"id":"W4280528160","doi":"10.1038/s41591-022-01789-0","title":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","year":2022,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Medical Research Council; Versus Arthritis; Servier; Efficacy and Mechanism Evaluation Programme; National Institute for Health and Care Research; Cancer Research UK; Arthritis Society","keywords":"Rituximab; Tocilizumab; Medicine; Rheumatoid arthritis; Biomarker; Internal medicine; Clinical trial; Biopsy; Oncology; Monoclonal antibody; Immunology; Pathology; Antibody; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002915761,0.0003045253,0.002228582,0.001384677,0.0002405826,0.00001315526,0.0004045083,0.000212785,0.003402899],"category_scores_gemma":[0.003523909,0.0001938152,0.0007583832,0.003807703,0.0009291507,0.00005983777,0.0001303163,0.001449057,0.000003627945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002030102,"about_ca_system_score_gemma":0.0005034729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004829071,"about_ca_topic_score_gemma":0.0002508168,"domain_scores_codex":[0.9950181,0.001046222,0.001074791,0.0004776621,0.001893384,0.0004898583],"domain_scores_gemma":[0.9971942,0.001310797,0.0003424844,0.0007588157,0.0002039767,0.0001897671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9764251,0.001677184,0.0002390473,0.00003019616,0.001969491,0.0001710918,0.0004882668,0.00002482981,0.002149262,0.0007920477,0.00162619,0.01440728],"study_design_scores_gemma":[0.9849518,0.001783688,0.0003545659,0.0003169845,0.0002211444,0.00004091195,0.0005064047,0.003938848,0.0004306349,0.0001330152,0.007149681,0.0001723111],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9419499,0.04416564,0.00007054264,0.007891905,0.001798962,0.002712841,0.0001512077,0.00006056535,0.001198418],"genre_scores_gemma":[0.9955459,0.003010214,0.00008163021,0.0004326443,0.0001146033,0.0004264538,0.0002940735,0.00003057611,0.00006385981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05359603,"threshold_uncertainty_score":0.9975081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01719248222998366,"score_gpt":0.3299646269235322,"score_spread":0.3127721446935485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}